At the news
? NEUTRALIMPACT 2/10 3 filed Apr 20, 2026 at 17:36 ET
Dr. Mark Peters filed a Form 3 to report his initial ownership of Oklo Inc. securities and appointed several executives as his attorneys-in-fact to handle SEC filings on his behalf. This is a routine regulatory disclosure required under Section 16 of the Securities Exchange Act.
- Dr. Mark Peters filed a Form 3 to report initial beneficial ownership of Oklo Inc. (OKLO) securities.
- The filing is a routine regulatory requirement under Section 16 of the Securities Exchange Act.
- Peters appointed Jacob DeWitte, Caroline DeWitte, Richard Craig Bealmear, and Vivek Narayanadas as attorneys-in-fact to handle SEC filings on his behalf.
- The filing does not disclose any specific financial details or ownership amounts.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access